CATALOGO DEI PRODOTTI DELLA RICERCA

BERTAZZONI MINELLI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.956
EU - Europa 14.622
AS - Asia 10.292
SA - Sud America 1.194
AF - Africa 155
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 14
Totale 42.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.786
SG - Singapore 4.738
RU - Federazione Russa 4.190
GB - Regno Unito 3.576
CN - Cina 2.976
IT - Italia 1.931
BR - Brasile 970
FR - Francia 937
SE - Svezia 933
DE - Germania 910
VN - Vietnam 701
FI - Finlandia 696
IE - Irlanda 670
HK - Hong Kong 622
KR - Corea 339
UA - Ucraina 327
JP - Giappone 166
IN - India 132
NL - Olanda 94
TR - Turchia 94
CA - Canada 91
AR - Argentina 85
BE - Belgio 72
BD - Bangladesh 71
IQ - Iraq 61
PL - Polonia 54
SA - Arabia Saudita 51
ID - Indonesia 50
MX - Messico 47
ES - Italia 45
PK - Pakistan 45
IR - Iran 37
ZA - Sudafrica 35
EC - Ecuador 33
AU - Australia 32
UZ - Uzbekistan 28
CO - Colombia 24
MA - Marocco 24
CL - Cile 21
LT - Lituania 20
KE - Kenya 19
NG - Nigeria 19
NP - Nepal 19
PE - Perù 19
RO - Romania 19
CH - Svizzera 18
IL - Israele 18
EG - Egitto 17
AT - Austria 16
CZ - Repubblica Ceca 15
KZ - Kazakistan 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 14
JO - Giordania 14
TN - Tunisia 14
BG - Bulgaria 13
DZ - Algeria 13
PY - Paraguay 13
OM - Oman 12
MY - Malesia 11
PH - Filippine 11
AZ - Azerbaigian 10
BY - Bielorussia 10
DK - Danimarca 10
PA - Panama 9
BO - Bolivia 8
EU - Europa 8
HU - Ungheria 8
PT - Portogallo 8
AM - Armenia 7
LB - Libano 7
NZ - Nuova Zelanda 7
AL - Albania 6
GR - Grecia 6
JM - Giamaica 6
QA - Qatar 6
EE - Estonia 5
ET - Etiopia 5
GE - Georgia 5
HR - Croazia 5
RS - Serbia 5
TH - Thailandia 5
UY - Uruguay 5
KG - Kirghizistan 4
LK - Sri Lanka 4
LV - Lettonia 4
MK - Macedonia 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
HN - Honduras 3
KW - Kuwait 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
CY - Cipro 2
DO - Repubblica Dominicana 2
LU - Lussemburgo 2
LY - Libia 2
MD - Moldavia 2
Totale 42.240
Salva come PNG Salva come JPEG
Città #
Southend 3.035
Jacksonville 2.926
Singapore 2.647
Chandler 2.068
Moscow 1.145
Woodbridge 1.128
Ashburn 1.125
San Jose 1.093
Dallas 922
Ann Arbor 758
Dublin 669
Hong Kong 606
Verona 580
Houston 549
The Dalles 500
Lawrence 320
Princeton 320
Wilmington 300
Nanjing 288
Beijing 287
Ho Chi Minh City 253
New York 242
Sindelfingen 240
Jinan 215
Los Angeles 213
Shenyang 198
Boardman 191
Buffalo 161
Tokyo 161
Hanoi 158
Milan 141
Hebei 140
Tianjin 140
Helsinki 138
Munich 119
Zhengzhou 101
Changsha 97
Ningbo 96
Nanchang 95
Rome 83
São Paulo 81
Haikou 78
Santa Clara 75
Brussels 71
Hangzhou 68
Frankfurt am Main 66
Jiaxing 66
Council Bluffs 65
Orem 64
Guangzhou 63
Taizhou 60
Seattle 59
Taiyuan 53
Norwalk 52
Chicago 42
Lanzhou 41
Redondo Beach 41
Da Nang 37
Chennai 36
London 35
Fairfield 34
Amsterdam 32
Rio de Janeiro 32
San Francisco 32
Columbus 31
Fuzhou 31
Toronto 31
Belo Horizonte 30
Turku 30
Warsaw 30
Atlanta 27
Edinburgh 27
Stockholm 27
Montreal 26
Tashkent 26
Manchester 25
Riyadh 25
Baghdad 24
Barnet 24
Haiphong 24
Redwood City 24
Naples 23
Brasília 21
Philadelphia 21
Johannesburg 20
Dearborn 19
Denver 19
Abuja 18
Boston 18
Florence 18
Jakarta 18
Nairobi 18
Phoenix 18
Düsseldorf 17
Brooklyn 16
Curitiba 16
Washington 16
Augusta 15
Bari 15
Lahore 15
Totale 26.534
Salva come PNG Salva come JPEG
Nome #
Proprietà farmacocinetiche e farmacodinamiche di antibiotici nel trattamento locale di infezioni protesiche 336
Influenza del sito d’ infezione (pancreas) sulla farmacocinetica e farmacodinamica di piperacillina-tazobactam 253
Medici a Verona: Indagine sui fattori di benessere/malessere dei professionisti veronesi 249
I medici veronesi e le problematiche deontologiche della professione 248
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 247
Analysis of intestinal microflora of autistic children before and after probiotic treatment. 243
Variability in the release of antibiotics from PMMA bone cement spacers 232
Carbenicillina e Sulbenicillina. Studi di farmacocinetica nel ratto. 228
Effetti del calcio policarbofil nel bambino con stipsi 218
Antibiotics penetration in human necrotizing pancreatitis (NP). 217
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 212
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 210
A new technique for evaluating the composition of faecal flora. 210
A simplified method for the evaluation of human flora in clinical practice. 208
[Antibacterial activity of rifampicin on faecal flora in rats] 206
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 206
Antibiotics and intestinal contents interaction 206
[Characterization of fosfomycin as a potential intestinal antibacterial agent. Studies in the rat] 202
Health-promoting properties of new lactobacilli strains: in vivo models 202
Different probiotics and intestinal microflora in antibiotic treated children 201
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 201
[In vivo comparative evaluation of the activity of antibacterial drugs on aerobic fecal flora] 200
Effect of dose on the intestinal concentrations of fluoroquinolones. Infection and Intensive care. Italian and British Perspectives 200
Commercial probiotic products: evaluation of microbial content and nomenclature 196
Safery and antibiotics concentrations in serum and urine after implantation of gentamicin-vancomycin-loaded spacers in patients with prosthetic joint infections 195
Sulfamidici e diaminopirimidine 195
Fluoroquinolones effects on patients lymphocytes during prolonged treatments 194
Diffusibilità di cefuroxim e cefoxitina in essudati pleurici ottenuti sperimentalmente nel ratto (pleurite da carragenina e da Bordetella pertussis). 193
Effetti dei fluorochinoloni in linfociti di pazienti in trattamenti protratti. 192
Evaluations of CYP 3A 4/5 and DNA damage in rat enterocytes and in human and rat lymphocytes by fluoroquinolones 191
Caratterizzazione della fosfomicina come potenziale antibatterico intestinale: studi nel ratto. 187
Antibiotici e pancreas esocrino: interazioni. 187
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORMS AND DNA DAMAGE IN RAT. 187
Assessment of novel probiotic Lactobacillus casei strains strains for the production of functional dairy foods. 185
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORM AND DNA DAMAGE IN RAT. 184
Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery. 184
Diffusione ossea dell'associazione gentamicina-vancomicina da impianto in PMMA in osteomielite sperimentale 183
Antibiotics and their interaction with intestinal contents. 182
Bacterial faecal flora in healthy women of different ages. 180
[Further research on the interference by oligosaccharide antibiotics in biosynthesis of the bacterial wall] 178
Effect of ceftriaxone along with probiotics administrationon intestinal ecosystem and beta-lactamase activity 177
Bacterial flora composition and faecal enzymes in pre- and postmenopausal women with breast cancer. 176
Su meccanismo d'azione degli antibiotici oligosaccaridici. 176
EFFETTI DI FLUOROCHINOLONI IN LINFOCITI DI PAZIENTI IN TRATTAMENTI PROTRATTI. 176
Interazione itraconazolo-ciprofloxacina nel compartimento intestinale del ratto: dati preliminari 176
Carbenicillina e sulbenicillina: studi di farmacocinetica nel ratto. 175
Health-promoting properties of new lactobacilli strains: in-vivo models 174
BACTERIAL ADHESION ON ANTIBIOTIC-LOADED POLYMETHYLMETHACRYLATE BONE CEMENT 174
CEFTRIAXONE THERAPY, INTESTINAL BETA-LACTAMASES AND INTERACTION WITH PROBIOTICS IN CHILDREN 174
Effect of pancreatic enzymes administration on intestinal ecosystem in patients with exocrine pancreatic insufficiency. Preliminary results 173
Fluoroquinolones (FQs) effects on enterocytes and lymphocytes. 171
Itraconazole-ciprofloxacin interaction on the pharmacokinetics of the intestinal compartment: preliminary results in rats 171
A serum antimicrobial activity of cancer patients and interaction with different antibacterial drugs. 169
Alterazioni quantitative e qualitative nella flora fecale in ratti alimentati con dieta iperlipidica. 169
Bacterial adhesion on antibiotic-loaded polymethylmethacrylate bone cement 169
Prophylaxis of P. carinii pneumonia (PCP). in HIV-infected patients with trimethoprim/sulfametoxazole (TMP/SMX) or dapsone (DDS) 168
Rischio di nefrotossicità per terapia locale con cementi ossei antibiotati (aminoglicosidi e glicopeptidi) nelle infezioni protesiche. 168
Effect of probiotics in the presence of antimicrobial therapy 167
Antibacterial activity of the combination of uraemic sera and betalactam antibiotics. 167
A different behaviour of antibiotics in presence of fresh intestinal content in vitro. 165
Alterazioni dell’ecosistema inestinale da antibiotici. problemi e prospettive 164
Piperacillin-Tazobactam penetration into human pancreatic juice 163
Dose-effect of fluoroquinolones on intestinal penetration, hepatic isoforms and DNA damage in the rat 163
Vancogenx-space for hip and knee: gentamicin and vancomycin levels in serum and urine from a multicenter trial 163
Microflora intestinale ed enzimi fecali in donne con fibromatosi uterina e tumore al seno. 162
Antibiotici e meccanismi di difesa dell'ospite 162
Attività antibatterica intestinale della meclociclina nel ratto. 162
Effetti sistemici ed intestinali dei fluorochinoloni 161
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer 161
Health promoting of new Lactobacilli strains: in-vivo models. 159
Changes in rat intestinal microflora following oral and parenteral administration of antimicrobial drugs 158
Valutazione della compliance al dapsone (DDS) in pazienti in profilassi per PCP. 158
Commercial probiotic products: evaluation of microbial content and nomenclature. 158
Antibacterial interaction of cefuroxime and serum from uraemic patients. 155
Attività antimicrobica del siero di pazienti cancerosi ed interazioni farmacologiche con diversi farmaci antibatterici 155
Twice-weekly dapsone for primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1 infection: comparative efficacy and pharmacokinetic data. 154
Intestinal ecosystem and metabolic capacity in women with breast cancer 154
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 153
Osservazioni cliniche e sperimentali sul problema delle interazioni tra farmaci. 152
Imipenem (IMP) penetration into pancreatic tissue during acute necrotizing form (NP). 152
Antibacterial activity of endogenous substances present in biological fluids. 152
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. 152
Different effect of pre-treatment with phenobarbital on transintestinal elimination of moxifloxacin and ciprofloxacin: preliminary data 151
Changes in faecal microflora enzymes and bacterial composition related to uterine leiomyoma and breast cancer 150
Variability in the release of antibiotics from PMMA bone cement spacers 150
Caratterizzazione della fosfomicina. 148
Sulfamidici e diaminopirimidine 148
Rilascio di antibiotici da spaziatori antibiotati nei fluidi di drenaggio 147
Rilascio locale dell’associazione gentamicina-vancomicina da chiodo endomidollare in osteomielite sperimentale 147
Release of antibiotics from polymethylmethacrylate cement 146
Attività degli antibiotici nei sistemi biologici 146
Premenstrual syndrome (PMS): effect of probiotic supplement and S-adenosyl-L-methionine (SAMe) on intestinal microflora. 146
DRAINAGE AND SERUM LEVELS OF ANTIBIOTICS FOLLOWING TEMPORARY SPACER IMPLANTS IN TWO-STAGE REVISION SURGERY 146
Interference of gentamicin and other oligosaccharides antibiotics on the biosynthesis of the bacterial cell-wall. 145
Pefloxacin penetration into human necrotic pancreatic tissue. 145
Attività antibatterica intestinale della rifampicina nel ratto. 144
Antimetabolites. 143
Intestinal microflora and faecal enzymes in women with uterine leiomyoma and breast cancer. 143
Antibiotic release from removed temporary hip spacers 143
Metronidazole (MZ) penetration into pancreatic juice (P5) and necrotic pancreatic tissue (NPT). 142
Totale 17.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.688
article - articoli 47.294
book - libri 0
conference - conferenze 68.915
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.479
Totale 255.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021677 0 0 0 0 0 0 0 0 0 52 505 120
2021/20222.457 207 591 37 194 113 87 54 127 96 81 226 644
2022/20235.647 458 439 602 884 593 1.220 60 474 517 50 270 80
2023/20242.230 137 253 165 370 190 251 83 234 38 48 226 235
2024/20255.757 431 562 212 914 357 49 213 326 944 276 348 1.125
2025/202613.317 1.130 689 971 1.965 3.354 1.377 1.461 721 930 719 0 0
Totale 42.588